Article info
Electronic pages
Correspondence
The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region
- Correspondence to Dr Stéphane Paul, Department of Immunology, CHU Saint-Etienne, Saint-Etienne 42023, France; stephane.paul{at}chu-st-etienne.fr
Citation
The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region
Publication history
- Received February 25, 2015
- Accepted February 28, 2015
- First published March 23, 2015.
Online issue publication
July 09, 2015
Article Versions
- Previous version (23 March 2015).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions